1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.

Repligen Corp.

XNAS: RGEN

Momentum Trap
Download real time

131.10 4.48 (3.54%)

28.17% Fall from 52W High

408.5K XNAS Volume

XNAS 16 Apr, 2025 12:06 PM (EDT)

Watchlist

Portfolio

Share
7S
13W
5O
0T
7,365.1

Market Cap

High in industry
-288.7

PE TTM

Negative PE TTM
1.7

PEG TTM

PEG TTM is much higher than 1
3.7

Price to Book

Below industry Median
0.8

Beta 1Year

Very Low volatility

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 19 analysts

Repligen Corp. has a share price target of US$ 190, revenue growth forecast of 10.4%, and profit growth estimate of 313.5% for FY25, based on top 19 analyst calls.

Forecaster Screeners